-
ERA PerMed Newsletter published
14 January 2022 – In their just published 7th Newsletter, ERA PerMed presents the projects funded under Joint Transnational Call 2021 “development of clinical support tools for personalised medicine implementation”.
-
New publication of the CSA PERMIT
11 January 2022 – The CSA PERMIT (PERsonalised Medicine Trials) published a scoping review on the topic of machine learning methods for patient stratification. It highlights common elements of successful biomarker discovery stories.
-
XIIIth ICPerMed Newsletter is online
09 December 2021 – ICPerMed published its XIIIth Newsletter informing interested stakeholders about new developments, important events and research progress in the field of personalised medicine.
-
Fifth ERA PerMed Call for Proposals now open
01 December 2021 – New funding opportunities for transnational Research projects in Personalised Medicine: As of today, ERA PerMed launched their latest call for proposals. This year’s topic is „Prevention in Personalised Medicine“. An open information day introducing the joint transnational call 2022 to the research community will be organised by ERA PerMed on December…
-
Review: Virtual Executive Committee Meeting
1 December 2021 – On 29-30 November 2021, the ICPerMed Executive Committee met virtually to discuss and plan strategy and future activities of the consortium.
-
ICPerMed “Best Practice in Personalised Medicine” Recognition 2021
30 November 2021 – ICPerMed launched its fourth Recognition. The objective of the ICPerMed Recognition 2021 is to honour, encourage, promote and disseminate outstanding evidence-based applications in the field of personalised medicine (PM), focusing on the implementation of PM research. The deadline for proposal submission was 18 February 2022. The Recognition was open to candidates…
-
Translational medicine in Familial hypercholesterolaemia – the Portuguese FH Study
Familial Hypercholesterolaemia (FH) is an inherited disorder of lipid metabolism. Patients suffer from high cholesterol levels since birth. If this is not treated, their risk for a cardiovascular disorder is very high. Genetic analysis can predict the severity of the disease and allows to choose the best, personalised treatment from a wide variety of options,…
-
EU-Africa PerMed information day
22 November 2021 – On December 1st and 13th, two information days of the CSA EU-Africa PerMed will take place. These are in preparation of the first EU-Africa PerMed workshop that is planned for February next year. The EU-Africa PerMed project seeks to develop international collaborations and to identify future actions in personalised medicine to…
-
Information Leaflets for ICPerMed Working Groups
08 November 2021 – Interested in finding out more about the aims and activities of ICPerMed working groups? Information leaflets informing about the aims and activities of the groups are now available. The ICPerMed Working Groups consist of ICPerMed members and external experts and support ICPerMed activities. They work on topics prioritized by ICPerMed.
-
Personalised Medicine Workshop of the Paul-Ehrlich-Institute
27 October 2021 – The Paul-Ehrlich-Institute in Germany invites to a virtual workshop: “The Next Frontiers in Development and Clinical Application of Personalized Medicines” on November 15, 2021. The aim of the workshop is to present the current state of the art in personalized medicine and to explore the challenges in research and innovation to…
